US Stock MarketDetailed Quotes

CMPS COMPASS Pathways

Watchlist

4.140
-0.440-9.61%

Close Jan 8 16:00 ET

4.180
+0.040+0.96%

Post 20:01 ET

283.26MMarket Cap-1.90P/E (TTM)

COMPASS Pathways Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

COMPASS Pathways Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--
Oct 31, 2024	2024/Q3	0.000 / 0.000	--
Aug 1, 2024	2024/Q2	0.000 / 0.000	--
May 8, 2024	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

Oct 31, 20242024/Q30.000 / 0.000--

Aug 1, 20242024/Q20.000 / 0.000--

May 8, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

COMPASS Pathways Earnings Reports

COMPASS Pathways | 8-K: Compass Pathways Announces Third Quarter 2024 Financial Results and Business Updates

Oct 31, 2024 06:36 ET

COMPASS Pathways | 10-Q: Q3 2024 Earnings Report

Oct 31, 2024 06:36 ET

COMPASS Pathways | 8-K: Compass Pathways announces second quarter 2024 financial results and business highlights

Aug 1, 2024 06:36 ET

COMPASS Pathways | 10-Q: Q2 2024 Earnings Report

Aug 1, 2024 06:36 ET

Trending US Stocks

Symbol Mini Chart % Chg

Collegium Pharmaceutical

Halozyme Therapeutics

Unlock the Full List

Analysis

Analyst Rating

Updated: Jan 9, 2025

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data